In Malaysia, clinical trial data are crucial for drug registration, providing evidence of safety, efficacy, and quality. The National Pharmaceutical Regulatory Agency (NPRA) evaluates these data to ensure compliance with regulatory standards, guiding approval decisions. This process ensures that new drugs meet necessary health and safety requirements before market entry.